The stock market’s persistent rise to new heights has left many top-rated dividend stocks overlooked. Amid this frenzy, W.P. Carey (NYSE: WPC) and Royalty Pharma (NASDAQ: RPRX) are two compelling additions that should be considered further for investing in dips. Both stocks are available at their 52-week lows at reasonable valuations accompanied by a steady,

Nifty has been the talk of the towns for a long now. Of its quick profit-generation properties and stability over time, investors wonder if now is the right time to jump or be careful before making any move. Let’s discuss data-driven information and give an opinion about whether the returns from Nifty in two years

Shares of Wipro were in the limelight on December 3rd as the stock opened at ₹295.35 on the National Stock Exchange (NSE). However, it traded in a very narrow range between ₹296.20 and ₹289.30. The bonus issue gives the shareholders one extra share of equity for each fully paid share of equity that is held.

Worries about the broader impact of bribery allegations against the Adani Group have rattled market sentiment in India, but global investors remain optimistic about the country’s long-term prospects. They argue India’s robust economic growth and vast consumer base continue to attract foreign capital despite recent turbulence. The US charges the Adani Group’s ports-to-energy conglomerate of

Much-awaited C2C Advanced Systems IPO opened for subscription on Friday, November 22. This is a public offering of the company that would raise ₹99.07 crore by issuing 43.84 lakh fresh equity shares. Investment enthusiasts are eyeing this money-making opportunity to take part in the growth story of the company. Since the IPO of C2C Advanced

On Thursday, South Korean stock market was badly hit as the KOSPI index declined to about 2% on November 12, which marked the first time in three months that it had closed beneath the critical mark of 2,500. The KOSPI ended at 2,482.57 after falling by about 1.94 percent from the previous session, with investors

Niva Bupa Health Insurance shares will hit Dalal Street on Thursday, November 14. According to market signals, the listing of Niva Bupa Health is going to be timid. Even on the grey market, the premium or GMP for the stock ahead of the IPO launch was seen trading at just Rs 1, suggesting that the